R. Pruzan

发表

Interaction of human telomerase with its primer substrate.

K. Pongracz, S. Gryaznov, G. Wallweber, 2003, Biochemistry.

Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.

K. Pongracz, S. Gryaznov, G. Wallweber, 2002, Nucleic acids research.

Transcription of adenovirus RNA polymerase III genes.

S. J. Flint, R. Pruzan, 1995, Current topics in microbiology and immunology.

Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents.

C. Harley, J. Shay, A. Asai, 2001, Nucleosides, nucleotides & nucleic acids.

A novel telomerase template antagonist (GRN163) as a potential anticancer agent.

C. Harley, S. Akinaga, A. Asai, 2003, Cancer research.

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

Gregg B. Morin, C. Harley, G. Morin, 1997, Nature Genetics.

Stereopure oligonucleotide phosphorothioates as human telomerase substrates

B. Nawrot, S. Gryaznov, D. Zielińska, 2010 .

Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA.

C. Autexier, C. Greider, W. Funk, 1996, The EMBO journal.

Assemblage of the prespliceosome complex with separated fractions isolated from HeLa cells.

J. Hurwitz, H. Furneaux, R. Pruzan, 1990, The Journal of biological chemistry.

Oligonucleotide N3′ → P5′ Thio-phosphoramidate Telomerase Template Antagonists as Potential Anticancer Agents

C. Harley, S. Akinaga, A. Asai, 2003, Nucleosides, nucleotides & nucleic acids.

Novel Short Oligonucleotide Conjugates as Inhibitors of Human Telomerase

J. Shay, B. Herbert, K. Pongracz, 2003, Nucleosides, nucleotides & nucleic acids.

Elements involved in an in vitro block to transcription elongation at the end of the L1 mRNA family of adenovirus 2.

O. Resnekov, Y. Aloni, R. Pruzan, 1991, Nucleic acids research.

Attenuation in the Control of Gene Expression in Animal Viruses

N. Hay, A. Ben-Ze'ev, E. Ben‐Asher, 1984 .

Specific transcription from the adenovirus E2E promoter by RNA polymerase III requires a subpopulation of TFIID.

S. J. Flint, P. K. Chatterjee, R. Pruzan, 1992, Nucleic acids research.

In vitro premature termination in SV40 late transcription.

N. Hay, P. Pfeiffer, Y. Aloni, 1983, The EMBO journal.

Purification of an active TATA-binding protein-containing factor using a monoclonal antibody that recognizes the human TATA-binding protein.

S. J. Flint, P. K. Chatterjee, R. Pruzan, 1993, Protein expression and purification.